Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing

The feasibility of rapid genetic testing in patients undergoing percutaneous coronary intervention (PCI) and the comparison of the pharmacodynamic effects of prasugrel versus ticagrelor among carriers of cytochrome P450 2C19 loss-of-function alleles treated with PCI has been poorly explored. Rapid g...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JACC Basic Transl Sci
Glavni autori: Franchi, Francesco, Rollini, Fabiana, Rivas, Jose, Rivas, Andrea, Agarwal, Malhar, Briceno, Maryuri, Wali, Mustafa, Nawaz, Ahmed, Silva, Gabriel, Shaikh, Zubair, Maailiki, Naji, Been, Latonya, Pineda, Andres M., Suryadevara, Siva, Soffer, Daniel, Zenni, Martin M., Bass, Theodore A., Angiolillo, Dominick J.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
CLINICAL RESEARCH
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7251226/
https://ncbi.nlm.nih.gov/pubmed/32478205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2020.02.009
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items